Hengrui Pharmaceutical announced that on October 16, 2026, the company will repurchase 195,000 A-shares through the Shanghai Stock Exchange. The repurchased shares will be used for A-share employee stock ownership plans and will be held as treasury shares. The repurchase price range was 45.60 yuan to 46.33 yuan per share, and the total transaction amount was 8.9971 million yuan. This repurchase accounted for 0.003% of the shares issued before the incident. After the repurchase was completed, the total number of shares issued by the company remained unchanged, and the treasury stock increased to 127.13,900 shares.

Hengrui Pharmaceutical announced that on October 16, 2026, the company will repurchase 195,000 A-shares through the Shanghai Stock Exchange. The repurchased shares will be used for A-share employee stock ownership plans and will be held as treasury shares. The repurchase price range was 45.60 yuan to 46.33 yuan per share, and the total transaction amount was 8.9971 million yuan. This repurchase accounted for 0.003% of the shares issued before the incident. After the repurchase was completed, the total number of shares issued by the company remained unchanged, and the treasury stock increased to 127.13,900 shares.